Shareholder Information
General Shareholder Information
1. Listing on Stock Exchanges and Security Codes :| Name of Stock Exchange | Security Code |
| A. Equity shares | |
| BSE Limited, Mumbai (BSE) | 500420 |
| National Stock Exchange of India Limited, Mumbai (NSE) | TORNTPHARM |
| B. Non-Convertible Debentures | |
| National Stock Exchange of India Limited, Mumbai (NSE) |
The Company has paid the annual listing fees for the year 2022-23 to both the above stock exchanges.
2. Distribution of shareholding as at 31 st March, 2023 :
By size of shareholding :
| Category (Shares) | Mode of Holding | No. of Shares | % To Equity | No. of Holders | % To Holders |
| 1 - 1,000 | Electronic | 6,927,441 | 2.05 | 61,152 | 93.25 |
| Physical | 115,929 | 0.03 | 368 | 0.56 | |
| 1,001 – 2,000 | Electronic | 3,434,716 | 1.01 | 2,279 | 3.48 |
| Physical | 426,720 | 0.13 | 268 | 0.41 | |
| 2,001 – 10,000 | Electronic | 4,061,441 | 1.20 | 960 | 1.46 |
| Physical | 102,960 | 0.03 | 27 | 0.04 | |
| 10,001 – 20,000 | Electronic | 2,304,888 | 0.68 | 163 | 0.25 |
| Physical | 43,200 | 0.01 | 3 | 0.00 | |
| Above 20,000 | Electronic | 321,028,145 | 94.85 | 361 | 0.55 |
| Physical | 0 | 0.00 | 0 | 0.00 | |
| Total | Electronic | 337,756,631 | 99.80 | 64,915 | 98.99 |
| Physical | 688,809 | 0.20 | 666 | 1.01 | |
| Total | 338,445,440 | 100.00 | 65,581 | 100.00 |
By category of shareholders :
Category |
No. of Shares |
Total Shares |
% of Holding |
|
Electronic |
Physical |
|||
| Promoter's Group | 241,129,440 | 0 | 241,129,440 | 71.25 |
| Mutual Fund | 21,574,859 | 0 | 21,574,859 | 6.37 |
| Bank, FIs, AIFs & Insurance Companies | 6,546,572 | 0 | 6,546,572 | 1.93 |
| Foreign Institutional Investors/QIB/QFIs/NRIs | 41,342,739 | 0 | 41,342,739 | 12.22 |
| Bodies Corporate | 1,124,524 | 5,255 | 1,129,779 | 0.33 |
| Indian Public | 19,184,773 | 683,554 | 19,868,327 | 5.87 |
| Others | 6,493,512 | 0 | 6,493,512 | 1.92 |
| IEPF | 360,212 | 0 | 360,212 | 0.11 |
| Total | 337,756,631 | 688,809 | 338,445,440 | 100.00 |
3. Market Price Data :
| Monthly Share Price movement during the financial year ended 31 st March, 2023 at BSE & NSE: (Share price in Rs.) |
||||||
| Month | BSE | NSE | ||||
| High | Low | Volume | High | Low | Volume | |
| Apr-22 | 1,452.28 | 1,345.50 | 1,50,852 | 1,451.98 | 1,345.05 | 55,38,418 |
| May-22 | 1,476.95 | 1,242.50 | 4,10,260 | 1,477.45 | 1,242.08 | 1,38,39,514 |
| Jun-22 | 1,465.23 | 1,343.88 | 1,16,722 | 1,464.50 | 1,359.20 | 50,63,330 |
| Jul-22 | 1,538.40 | 1,421.00 | 3,92,944 | 1,539.00 | 1,419.03 | 66,28,370 |
| Aug-22 | 1,605.00 | 1,503.00 | 2,07,238 | 1,605.00 | 1,480.40 | 53,31,762 |
| Sep-22 | 1,565.00 | 1,449.25 | 4,06,155 | 1,565.90 | 1,448.80 | 75,62,625 |
| Oct-21 | 1,655.00 | 1,549.70 | 5,19,920 | 1,655.00 | 1,549.30 | 54,68,582 |
| Nov-22 | 1,722.70 | 1,597.80 | 98,052 | 1,750.00 | 1,596.55 | 61,06,650 |
| Dec-22 | 1,661.05 | 1,531.25 | 61,163 | 1,664.00 | 1,544.00 | 53,25,677 |
| Jan-23 | 1,632.00 | 1,507.05 | 59,206 | 1,632.35 | 1,507.50 | 35,29,137 |
| Feb-23 | 1,579.85 | 1,454.30 | 58,188 | 1,572.05 | 1,454.00 | 43,79,479 |
| Mar-23 | 1,563.00 | 1,446.15 | 84,777 | 1,564.90 | 1,445.55 | 50,18,935 |
| Total | 25,65,477 | 7,37,92,479 | ||||
| % of volume traded to outstanding shares | 0.76% | 21.80% | ||||
4. Other Information :
a. Dematerialisation of securities :
The equity shares of the Company are traded compulsorily in the dematerialised segment of all the stock exchanges and are under rolling settlement. Approximately 99.80% of the shares have been dematerialised. Shares held by promoters are all in dematerialised form. The demat security (ISIN) code for the equity share is INE685A01028.
b. Share Transfer System :
SEBI vide its circular dated 25th January 2022, has mandated that listed companies shall issue the securities in dematerialized form only, in order to enhance ease of dealing in securities markets by investors, for transactions including Issue of duplicate securities certificate, claim from unclaimed suspense account, renewal / exchange of securities certificate, endorsement, sub-division / splitting of securities certificate, consolidation of securities certificates/folios, transmission and transposition of shares. Accordingly, Shareholders are requested to make service requests by submitting a duly filled and signed Form ISR – 4, the format of which is available on the Company’s website under the link at https://www.torrentpharma.com/index.php/investors/shareHolder. The details of transmission approved by the delegates are noted by the Securities Transfer and Stakeholders Relationship Committee. The Company obtains from a Company Secretary in Practice an annual certificate of compliance with the share transfer formalities as required under Regulation 40(9) of the Listing Regulations and files a copy of the certificate with the Stock Exchanges. The Company has signed necessary agreements with two depositories currently functional in India viz. National Securities Depository Limited & Central Depository Services (India) Limited. The transfer of shares in electronic mode need not be approved by the Company.
The Company has sent individual letters to all the Members holding shares of the Company in physical form for furnishing / updating their PAN, KYC details and Nomination pursuant to the SEBI Circular dated 16 th March, 2023. Attention of the Members holding shares of the Company in physical form is invited to go through the said important communication under the web link at https://www.torrentpharma.com/index.php/investors/shareHolder.
c. Physical Transfers Pending (as on 31-Mar-23):
99.80% of the equity shares of the Company are held in dematerialised form & the handling of physical transfer of shares are minimal.
d. Complaints Pending (as on 31-Mar-23):
During the year, the Company has received 14 (fourteen) complaints from shareholders which were attended within a reasonable period of time. One (1) complaint was pending as on 31st March, 2023.
5. Investor services :
The investor related queries may be addressed to:
investorservices@torrentpharma.com
Registrars & Transfer Agents
KFin Technologies Limited, |
Unit: Torrent Pharmaceuticals Limited, Toll Free/ Phone Number: 040-67162222, Fax: 040-2300 1153. E-mail: einward.ris@kfintech.com |
Compliance Officer Chintan M Trivedi, |
Torrent Pharmaceuticals Limited, Telephone: 91-79-2659 9000 |
Shareholders holding shares in electronic mode should address their correspondence related to change in their records, viz. address, bank account details, etc., to the depository participant with whom they hold the account.Download
Information to be provided to RTA, if holding shares in physical form
The Securities and Exchange Board of India (‘SEBI’) vide its circular dated 03 rd November 2021 has made it mandatory for the shareholders holding securities in physical form to furnish PAN, KYC details and Nomination to the Registrar and Transfer Agent (‘RTA’) of the Company. In case of failure to provide required documents and details as per the aforesaid SEBI circular, all folios of such shareholders shall be frozen on or after 01 st April 2023 by the RTA. Further SEBI vide its circular
dated 14 th December, 2021 has issued clarification with respect to its earlier circular dated 3 rd November, 2021.
Click here for SEBI Circular:https://www.sebi.gov.in/legal/circulars nov-2021/common-and-simplified-norms-for-processing-investor-s-service-request-by-rtas-and-norms-for-furnishing-pan-kyc-details-and-nomination_53787.html and
https://www.sebi.gov.in/legal/circulars/dec-2021/clarifications-with-respect-to-circular-dated-november-03-2021-on-common-and-simplified-norms-for-processing-investor-s-service-request-by-rtas-and-norms-for-furnishing-pan-kyc-details-_54602.html
- PAN
- Nomination (for all eligible folios) in Form No. SH-13 or submit declaration to ‘Opt-out’ in Form ISR-3. Any cancellation or change in nomination shall be provided in Form No. SH-14. Said Forms can be downloaded from the link provided in table at sr no. 5 and 6 respectively.
- Contact details including Postal address with PIN code, Mobile Number, E-mail address
- Bank Account details including Bank name and branch, Bank account number, IFS code
- Specimen signature
The above documents/details are to be provided in hard copy to Company’s RTA i.e. KFin Technologies Private Limited, Selenium Tower B, Plot No.31-32, Gachibowli, Financial District, Nanakramguda, Serilingampally, Hyderabad 500 032, Telangana, India or through electronic mode with e-signature through email at einward.ris@kfintech.com along with Name and folio numbers.
Further, SEBI vide its circular dated January 25, 2022, has mandated that listed companies shall issue the securities in dematerialized form only, in order to enhance ease of dealing in securities markets by investors, for transactions including Issue of duplicate securities certificate, claim from unclaimed suspense account, renewal / exchange of securities certificate, endorsement, sub-division / splitting of securities certificate, consolidation of securities certificates/folios, transmission and transposition of shares.
In view of the above, the securities holder/claimant shall submit duly filled up Form ISR-4 which can be downloaded on the link provided on below table at sr.no. 4 along with the documents / details specified in the SEBI Circular.Click here for SEBI Circular:https://www.sebi.gov.in/legal/circulars/jan-2022/issuance-of-securities-in-dematerialized-form-in-case-of-investor-service-requests_55542.html
The shareholders can download the forms mentioned in SEBI circular as given below:
| Sr. No. | Form | Purpose | Download Form |
| 1 | Form ISR-1 | Request for Registering PAN, KYC details OR Changes/updations there of (only for securities held in physical form) | Download Form |
| 2 | Form ISR-2 | Confirmation of Signature of securities holder by Banker | Download Form |
| 3 | Form ISR-3 | Declaration for Opting-out of Nomination by holders of physical securities in Listed Companies | Download Form |
| 4 | Form ISR-4 | Request for issue of Duplicate Certificate and other Service Requests | Download Form |
| 5 | Form SH-13 | Nomination Form | Download Form |
| 6 | Form SH-14 | Cancellation or Variation of Nomination | Download Form |
For SEBI Circular dated May 30, 2022 relating to Standard Operating Procedures (SOP) for dispute resolution under the Stock Exchange arbitration mechanism for disputes between a Listed Company and/or Registrars to an Issue and Share Transfer Agents (RTAs) and its Shareholder(s)/Investor(s), Click here.